Drug General Information
Drug ID
D04QEO
Former ID
DNC007490
Drug Name
KNI-10332
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528767]
Structure
Download
2D MOL

3D MOL

Formula
C38H46N4O6S2
Canonical SMILES
CC1=CC(=CC=C1)CC(=O)NC(CSC)C(=O)NC(CC2=CC=CC=C2)C(C(=O)<br />N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O
InChI
1S/C38H46N4O6S2/c1-23-11-10-14-25(17-23)19-31(44)39-29(21-49-4)35(46)40-28(18-24-12-6-5-7-13-24)33(45)37(48)42-22-50-38(2,3)34(42)36(47)41-32-27-16-9-8-15-26(27)20-30(32)43/h5-17,28-30,32-34,43,45H,18-22H2,1-4H3,(H,39,44)(H,40,46)(H,41,47)/t28-,29-,30+,32-,33-,34+/m0/s1
InChIKey
RKUUAMZSZJEKQE-DYCNJNKSSA-N
PubChem Compound ID
Target and Pathway
Target(s) Plasmepsin 2 Target Info Inhibitor [528767]
References
Ref 528767Bioorg Med Chem Lett. 2007 Jun 1;17(11):3048-52. Epub 2007 Mar 21.Additional interaction of allophenylnorstatine-containing tripeptidomimetics with malarial aspartic protease plasmepsin II.
Ref 528767Bioorg Med Chem Lett. 2007 Jun 1;17(11):3048-52. Epub 2007 Mar 21.Additional interaction of allophenylnorstatine-containing tripeptidomimetics with malarial aspartic protease plasmepsin II.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.